Marco Crescenzi
Marco Crescenzi
Verified email at iss.it
TitleCited byYear
Thermostable DNA polymerase chain amplification of t (14; 18) chromosome breakpoints and detection of minimal residual disease
M Crescenzi, M Seto, GP Herzig, PD Weiss, RC Griffith, SJ Korsmeyer
Proceedings of the National Academy of Sciences 85 (13), 4869-4873, 1988
3861988
α6β4 and α6β1 integrins associate with ErbB-2 in human carcinoma cell lines
R Falcioni, A Antonini, P Nistic˛, S Di Stefano, M Crescenzi, PG Natali, ...
Experimental cell research 236 (1), 76-85, 1997
2351997
MyoD induces growth arrest independent of differentiation in normal and transformed cells.
M Crescenzi, TP Fleming, AB Lassar, H Weintraub, SA Aaronson
Proceedings of the National Academy of Sciences 87 (21), 8442-8446, 1990
2301990
The mammalian mismatch repair pathway removes DNA 8-oxodGMP incorporated from the oxidized dNTP pool
C Colussi, E Parlanti, P Degan, G Aquilina, D Barnes, P Macpherson, ...
Current biology 12 (11), 912-918, 2002
2242002
New functions of XPC in the protection of human skin cells from oxidative damage
M D'Errico, E Parlanti, M Teson, BMB De Jesus, P Degan, A Calcagnile, ...
The EMBO journal 25 (18), 4305-4315, 2006
2232006
Human MRE11 is inactivated in mismatch repair‐deficient cancers
G Giannini, E Ristori, F Cerignoli, C Rinaldi, M Zani, A Viel, L Ottini, ...
EMBO reports 3 (3), 248-254, 2002
1822002
p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells
F Moretti, A Farsetti, S Soddu, S Misiti, M Crescenzi, S Filetti, M Andreoli, ...
Oncogene 14 (6), 729, 1997
1671997
Development of a highly efficient expression cDNA cloning system: application to oncogene isolation.
T Miki, TP Fleming, M Crescenzi, CJ Molloy, SB Blam, SH Reynolds, ...
Proceedings of the National Academy of Sciences 88 (12), 5167-5171, 1991
1671991
High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies.
L Lattanzi, G Salvatori, M Coletta, C Sonnino, MGC De Angelis, L Gioglio, ...
The Journal of clinical investigation 101 (10), 2119-2128, 1998
1641998
Interference with p53 protein inhibits hematopoietic and muscle differentiation.
S Soddu, G Blandino, R Scardigli, S Coen, A Marchetti, MG Rizzo, ...
The Journal of Cell Biology 134 (1), 193-204, 1996
1481996
Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain
L Fiorentino, C Pertica, M Fiorini, C Talora, M Crescenzi, L Castellani, ...
Molecular and cellular biology 20 (20), 7735-7750, 2000
1382000
Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint
T Bruno, F De Nicola, S Iezzi, D Lecis, C D'Angelo, M Di Padova, N Corbi, ...
Cancer cell 10 (6), 473-486, 2006
1042006
Np95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry
IM Bonapace, L Latella, R Papait, F Nicassio, A Sacco, M Muto, ...
The Journal of cell biology 157 (6), 909-914, 2002
952002
Terminally differentiated muscle cells are defective in base excision DNA repair and hypersensitive to oxygen injury
L Narciso, P Fortini, D Pajalunga, A Franchitto, P Liu, P Degan, M Frechet, ...
Proceedings of the National Academy of Sciences 104 (43), 17010-17015, 2007
932007
Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle
L Latella, A Sacco, D Pajalunga, M Tiainen, D Macera, M D'Angelo, ...
Molecular and Cellular Biology 21 (16), 5631-5643, 2001
932001
Anti-angiogenic gene therapy of cancer: current status and future prospects
L Persano, M Crescenzi, S Indraccolo
Molecular aspects of medicine 28 (1), 87-114, 2007
922007
Critical requirement for cell cycle inhibitors in sustaining nonproliferative states
D Pajalunga, A Mazzola, AM Salzano, MG Biferi, G De Luca, M Crescenzi
The Journal of cell biology 176 (6), 807-818, 2007
842007
The accumulation of MMS-induced single strand breaks in G 1 phase is recombinogenic in DNA polymerase β defective mammalian cells
B Pascucci, MT Russo, M Crescenzi, M Bignami, E Dogliotti
Nucleic acids research 33 (1), 280-288, 2005
822005
The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase
A Franchitto, P Pichierri, R Piergentili, M Crescenzi, M Bignami, F Palitti
Oncogene 22 (14), 2110, 2003
802003
The main biological determinants of tumor line taxonomy elucidated by a principal component analysis of microarray data
M Crescenzi, A Giuliani
Febs Letters 507 (1), 114-118, 2001
782001
The system can't perform the operation now. Try again later.
Articles 1–20